On-campus research laboratory activities moving forward
May 27, 2021
Dear Colleagues –
As we pivot forward from the COVID-19 pandemic challenges over the past 14 months, we have set revised operational parameters for on-campus laboratory research activities as listed below. These are planned for initial implementation effective June 1, 2021.
Please see the note from President Wilson on May 24, 2021 providing full considerations and guidelines for university plans and on-campus activities overall as we go forward.
Given the vaccination platforms and access in place, the engagement of all with responsible actions for safe and effective operations on site and the continued downward trends in the infectivity rates anchored with the increasing percentage of individuals receiving full vaccination, we expect laboratory research activity to move toward resumption of the same level of research activities as before the pandemic over the next few weeks.
Operational parameters for on-campus research laboratory activities moving forward:
The Human Research Protection Program will re-review participant risk on a case-by-case basis and this determination will be conducted through the submission of Appendix N - Resumption of In Person Human Participant Research Plan and PI Attestation.
To facilitate the IRB risk evaluation process, Appendix N should include specific operational parameters in place for Covid-19 mitigation including, but not limited to, masking, social distancing, vaccination of study personnel interacting with study participants, consideration of the duration of in-person contact with participants, and an established scheduling structure for coordinated participant visits and cleaning procedures between participant visits.
It is anticipated that beginning July 1, 2021, this platform for review and evaluation for studies classified as “without potential for direct benefit” will be extended to include non-affiliated study sites with appropriate additional operational considerations.
To report concerns regarding any aspect of the resumption of research activities and compliance with WSU Covid-19 policies, please use the WSU Internal Audit Anonymous tip form at https://internalaudit.wayne.edu/report and/or contact the WSU Integrity Officer, Phil Cunningham (firstname.lastname@example.org, 313-577-9064).
Finally, let me take this moment to convey my deepest appreciation to the entire research and campus community for their engagement, support and guidance during this journey over the past 14 months.
In addition to the personal responsibility for safe and effective operations at the local site, there has been a tremendous effort across campus from numerous divisions, units and support staff to enable safe and effective operations during this period. We are all indebted to the commitment of these individuals for all that they have done to assist, enable and facilitate on many fronts during this period and as we go forward.
Please do not hesitate to contact me or the VPR team if you have any questions. Please do let me know if there are any items that I may have missed and any suggestions or thoughts as we go forward.
Be sure to check the following links for updates and awareness of university initiatives and operations regularly:
Contact Information for Questions and Additional Information
Julie O'Connor, Director of Research Communications, Office of the Vice President for Research, email@example.com, Office: (313) 577-8845, Cell: (734) 748-4207
Antonio E. Yancey, Associate Vice President, Research Administrative Operations, firstname.lastname@example.org Office: (313) 577-1411
Direct line for concerns regarding safety and operational health: Research Integrity and Safety Office – Phil Cunningham, Ph.D., Associate VP for Research Integrity, email@example.com, Phone: (313) 577-9064, FAX: (313) 577-0384
Campus Health Center: (313) 577-5041 (accessible around the clock) https://health.wayne.edu/coronavirus/